ScinoPharm Taiwan Ltd Net Asset Quality Index
ScinoPharm Taiwan Ltd net asset quality index. ScinoPharm Taiwan Ltd (1789) has a Net Asset Quality Index of 87.0% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of NT$11.86 Billion minus total liabilities of NT$1.55 Billion yields net assets of NT$10.31 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 1789 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of ScinoPharm Taiwan Ltd (2007–2025)
Net asset quality index of ScinoPharm Taiwan Ltd from 2007 to 2025. This chart shows how ScinoPharm Taiwan Ltd's Net Asset Quality Index has evolved across 19 annual periods from 2007 to 2025. As of March 2026, the index stands at 87.0%, representing net assets of NT$10.31 Billion against total assets of NT$11.86 Billion TWD. See 1789 net assets for net asset value and shareholders' equity analysis.
ScinoPharm Taiwan Ltd Net Asset Quality Index by Year (2007–2025)
ScinoPharm Taiwan Ltd net asset quality index by year from 2007 to 2025. The table below presents the year-by-year Net Asset Quality Index for ScinoPharm Taiwan Ltd from 2007 to 2025, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ScinoPharm Taiwan Ltd (1789) market capitalisation.
| Year | Quality Index | Net Assets (TWD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 88.8% | NT$10.52 Billion | NT$11.86 Billion | NT$1.33 Billion | ▲ +0.6 pp |
| 2024 | 88.1% | NT$10.53 Billion | NT$11.94 Billion | NT$1.42 Billion | ▼ -0.3 pp |
| 2023 | 88.4% | NT$10.36 Billion | NT$11.72 Billion | NT$1.36 Billion | ▲ +0.7 pp |
| 2022 | 87.7% | NT$10.45 Billion | NT$11.91 Billion | NT$1.46 Billion | ▼ -2.2 pp |
| 2021 | 89.9% | NT$10.51 Billion | NT$11.69 Billion | NT$1.18 Billion | ▲ +1.0 pp |
| 2020 | 88.9% | NT$10.53 Billion | NT$11.85 Billion | NT$1.32 Billion | ▲ +1.0 pp |
| 2019 | 87.9% | NT$10.26 Billion | NT$11.67 Billion | NT$1.41 Billion | ▲ +4.0 pp |
| 2018 | 83.9% | NT$10.54 Billion | NT$12.56 Billion | NT$2.02 Billion | ▲ +1.9 pp |
| 2017 | 82.0% | NT$10.42 Billion | NT$12.70 Billion | NT$2.28 Billion | ▲ +2.0 pp |
| 2016 | 80.0% | NT$10.23 Billion | NT$12.78 Billion | NT$2.56 Billion | ▼ -0.6 pp |
| 2015 | 80.7% | NT$9.86 Billion | NT$12.22 Billion | NT$2.36 Billion | ▼ -1.8 pp |
| 2014 | 82.5% | NT$9.38 Billion | NT$11.37 Billion | NT$1.99 Billion | ▼ -1.5 pp |
| 2013 | 84.0% | NT$9.64 Billion | NT$11.48 Billion | NT$1.84 Billion | ▼ -3.8 pp |
| 2012 | 87.7% | NT$9.07 Billion | NT$10.34 Billion | NT$1.27 Billion | ▼ -2.6 pp |
| 2011 | 90.3% | NT$8.56 Billion | NT$9.48 Billion | NT$920.78 Million | ▼ -1.2 pp |
| 2010 | 91.5% | NT$6.68 Billion | NT$7.30 Billion | NT$620.97 Million | ▲ +14.7 pp |
| 2009 | 76.8% | NT$4.47 Billion | NT$5.82 Billion | NT$1.35 Billion | ▲ +17.1 pp |
| 2008 | 59.7% | NT$3.44 Billion | NT$5.76 Billion | NT$2.32 Billion | ▲ +14.8 pp |
| 2007 | 44.9% | NT$2.53 Billion | NT$5.64 Billion | NT$3.10 Billion | — |